Search details
1.
Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
Circulation
; 2024 Apr 07.
Article
in English
| MEDLINE | ID: mdl-38583093
2.
Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE.
Circulation
; 147(16): 1192-1203, 2023 04 18.
Article
in English
| MEDLINE | ID: mdl-36779348
3.
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease.
Circulation
; 146(15): 1109-1119, 2022 10 11.
Article
in English
| MEDLINE | ID: mdl-36031810
4.
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.
Eur Heart J
; 43(48): 5037-5044, 2022 12 21.
Article
in English
| MEDLINE | ID: mdl-36367709
5.
Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials: Insights From the TIMI trials.
Circulation
; 143(7): 685-695, 2021 02 16.
Article
in English
| MEDLINE | ID: mdl-33587654
6.
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials.
Lancet
; 396(10263): 1637-1643, 2020 11 21.
Article
in English
| MEDLINE | ID: mdl-33186535
7.
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
N Engl J Med
; 379(12): 1107-1117, 2018 09 20.
Article
in English
| MEDLINE | ID: mdl-30145941
8.
Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54.
Eur Heart J
; 41(17): 1625-1632, 2020 05 01.
Article
in English
| MEDLINE | ID: mdl-31811715
9.
Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials.
Circulation
; 140(16): 1308-1317, 2019 10 15.
Article
in English
| MEDLINE | ID: mdl-31530008
10.
Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial.
Circulation
; 140(12): 1004-1014, 2019 09 17.
Article
in English
| MEDLINE | ID: mdl-31362530
11.
Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus.
Circulation
; 139(17): 2022-2031, 2019 04 23.
Article
in English
| MEDLINE | ID: mdl-30786725
12.
Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial.
Circulation
; 139(3): 366-375, 2019 01 15.
Article
in English
| MEDLINE | ID: mdl-30586726
13.
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.
Circulation
; 139(12): 1483-1492, 2019 03 19.
Article
in English
| MEDLINE | ID: mdl-30586750
14.
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Lancet
; 393(10166): 31-39, 2019 01 05.
Article
in English
| MEDLINE | ID: mdl-30424892
15.
Cognitive Function in a Randomized Trial of Evolocumab.
N Engl J Med
; 377(7): 633-643, 2017 08 17.
Article
in English
| MEDLINE | ID: mdl-28813214
16.
Cardiac and Inflammatory Biomarkers Are Associated with Worsening Renal Outcomes in Patients with Type 2 Diabetes Mellitus: Observations from SAVOR-TIMI 53.
Clin Chem
; 65(6): 781-790, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30988169
17.
Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials.
Eur Heart J
; 39(42): 3810-3820, 2018 11 07.
Article
in English
| MEDLINE | ID: mdl-30239711
18.
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
N Engl J Med
; 372(25): 2387-97, 2015 Jun 18.
Article
in English
| MEDLINE | ID: mdl-26039521
19.
Long-term use of ticagrelor in patients with prior myocardial infarction.
N Engl J Med
; 372(19): 1791-800, 2015 May 07.
Article
in English
| MEDLINE | ID: mdl-25773268
20.
Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR-TIMI 53 outcome study.
Diabetes Obes Metab
; 19(7): 1045-1050, 2017 07.
Article
in English
| MEDLINE | ID: mdl-28181728